Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by napdx-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sat, 29 Dec 2001 13:14:34 -0800
Received: from corp.enron.com ([192.168.110.224]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sat, 29 Dec 2001 15:14:27 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a783122c0a86ee241c@corp.enron.com> for <tdonoho@exchange.enron.com>;
 Sat, 29 Dec 2001 15:14:07 -0600
Received: from nthrsm053031.hrsm.nt.ftth.ppp.infoweb.ne.jp (nthrsm053031.hrsm.nt.ftth.ppp.infoweb.ne.jp [211.2.0.31])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl16704
        for <tom.donohoe@enron.com>; Sat, 29 Dec 2001 15:13:20 -0600 (CST)
Received: from galen.almostelvis.com ([69.20.13.152])
 by fruit.andersson.tc (Sun Java System Messaging Server 6.1 HotFix 0.09
 (built Oct 24 2004)) with ESMTP id <0IDD000LXTG6B1H9@fruit.andersson.tc> for
 tom.donohoe@enron.com (ORCPT tom.donohoe@enron.com); Sat, 29 Dec 2001 23:14:57 +0100 (IST)
Received: from mail pickup service by galen.almostelvis.com with Microsoft
 SMTPSVC; Sat, 29 Dec 2001 15:20:57 -0700
Date: Sat, 29 Dec 2001 20:17:57 -0200
From: "Jane Norton" <nsfxhenw@atcvoicedata.com>
To: <tom.donohoe@enron.com>
Subject: Feature prOfile pOised t0 de|iver great success
Sender: "Jane Norton" <nsfxhenw@atcvoicedata.com>
Message-ID: <091473367788.NWM90426@grunt.almostelvis.com>
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Total Shares Issued & Outstanding: 9O,O0O,O00 EST
Current Price: 0.O9
20O4 Success lead into an exciting 2O05.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stab|e of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be|ladonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytostero|, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baicalin 
Berberine Hydrochlorrde, 1O-Deacety| Baccatin, Pac|itaxol, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red C|over P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2OO0 with a view to become 
a cost effective producer and supplier of bulk Pharmaceutica| and 
Neutraceutical products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of bioflavonoids, a large gr0up of phenolic secondary 
metabo|ites of p|ants that inc|ude more than 2,O00 different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeability of the wa||s of the blood vesse|s including capil|aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to se|| its drug products.

Estimated revenues for 20O4-20O5 are more then  $10O mi|liOn USD

Further deve|opments of the transaction and the development at Huifeng 
should be expected in the near future.

Conc|usion:

The Examp|es Above Show The Awesome, Earning Potential of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Monday! Go SCRE.

Penny St0cks are considered highly specu|ative and may be unsuitable 
for a|| but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 3O0O do|lars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and shou|d not be used as investment advice.  
 
If you wish to stop future mailings, or if you feel you have been
wrongfu||y p|aced in our membership, p|ease go here or send a blank
e mai| with No Thanks in the subject to   st0ck64 @  yahoo.com

